AMGEN’S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
THOUSAND OAKS, Calif., Nov. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) [...]
ABC Hosts Three Signature Events at AHA25 in New Orleans on November 8
ABC Events at AHA 2025 – Saturday, November 8 [...]
ABC Wants to Spotlight You at AHA25 — Submit Your Session Info by Nov. 5
Are you chairing, moderating, presenting, or participating in a panel [...]
ABC Members Featured Among Faculty for the Masters of Medicine 2026 Conference in Jamaica
ABC Members Featured Among Faculty for the Masters of [...]
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
AstraZeneca today announces the launch of AstraZeneca Direct, an online [...]
LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS
THOUSAND OAKS, Calif., Oct. 2, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today [...]
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
Voluntary agreement meets the President’s four requests while also protecting [...]
BridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025
PALO ALTO, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio [...]
The Policy Pulse Summit: Driving Cardiovascular Health Equity
The ABC Third Annual Policy Pulse Summit will bring together [...]
Association of Black Cardiologists Provides Free Heart Health Screenings at Cleveland’s Pop Up in the Park
Cleveland (Aug 31, 2025) – The Association of Black Cardiologists [...]